What is Medico Remedies Ltd (MEDICO) share price return in the past 10 years?

Data is not available for this company

What is the share price of Medico Remedies Ltd (MEDICO)?

Company share prices are keep on changing according to the market conditions. The current trading price of Medico Remedies Ltd (MEDICO) on 04-Jun-2026 16:59:59 at 16:59 is 45.83.

What is the P/E ratio of Medico Remedies?

The latest standalone P/E ratio of Medico Remedies as of 04-Jun-2026 is 28.99.

What is the P/B ratio of Medico Remedies Ltd (MEDICO)?

The latest standalone P/B ratio of Medico Remedies Ltd (MEDICO) as of 04-Jun-2026 is 5.04.

What is the 52-week high and low of Medico Remedies Ltd (MEDICO)?

The 52-week high of Medico Remedies Ltd (MEDICO) is Rs. 57.00 and the 52-week low is Rs. 31.00.

Medico Remedies Ltd (MEDICO) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Medico Remedies Ltd (MEDICO)
Brand: Medico Remedies

Medico Remedies Ltd (MEDICO)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540937 NSE: MEDICO Pharmaceuticals & Drugs | Small Cap | Medico Remedies Share Price

Medico Remedies Ltd (MEDICO)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540937 NSE: MEDICO Pharmaceuticals & Drugs | Small Cap | Medico Remedies Share Price

Key Metrics

Valuation Multiples

Market Cap

₹380 Cr.

Current Price

₹45.8

52-Week Low / High

₹31 / 57

TTM EPS

₹1.6

TTM Sales

₹206 Cr.

Book Value per Share

₹9.1

P/E Ratio

28.99

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

5.04

Lower than its 5-year historical median

Price to Sales (P/S)

1.84

Lower than its 5-year historical median

EV/EBITDA

17.30

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

17.58%

Outperforms industry median

Return on Capital Employed (ROCE)

21.65%

Outperforms industry median

Return on Assets (ROA)

9.18%

Operating Profit Margin

9.6%

Net Profit Margin

6.69%

Gross Profit Margin

11%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

4.15%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

11.7%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

21.71%

Asset Quality

Promoter Holding

61.38%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹59 Cr.

Equity

₹16.6 Cr.

Face Value

₹2

All Time Low / High

₹3.35 / 100.79

Medico Remedies stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is Medico Remedies Ltd a good quality company?

Medico Remedies Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Medico Remedies Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Medico Remedies Ltd vs industry peers?

Medico Remedies Ltd revenue CAGR is 11.23%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Medico Remedies Ltd?

Promoters hold 61.38% of the Medico Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Medico Remedies Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 50.91% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	10.9%	9.4%	9.1%	7.8%	7.7%	10.1%	15.1%	21.9%	21.9%	21.7%	-
Value Creation Index ⓘ	-0.2	-0.3	-0.4	-0.4	-0.5	-0.3	0.1	0.6	0.6	0.6	-
Growth Parameters ⓘ
Sales ⓘ	66.7	54.4	61	97.7	88.6	122	121	140	145	151	206
Sales YoY Gr.	-	-18.4%	12.1%	60.1%	-9.3%	38.1%	-1.1%	16.1%	3.2%	4.2%	-
Adj EPS ⓘ	0.2	0.3	0.1	0.1	0.1	0.3	0.4	0.6	0.8	1	1.6
YoY Gr.	-	66.7%	-66.7%	0%	-50%	420%	61.5%	31%	50.9%	20.5%	-
BVPS (₹) ⓘ	2.3	2.6	3.2	3.4	3.6	3.9	4.4	5.3	6.3	7.5	9.1
Adj Net Profit ⓘ	1.1	2	0.8	0.8	0.4	2.2	3.5	4.6	6.9	8.3	13
Cash Flow from Ops. ⓘ	-3.7	-3.2	5.1	4.9	1	-11.3	5.9	8.2	2.4	4.9	-
Debt/CF from Ops. ⓘ	-3.7	-6	2.5	2.7	14.4	-1.3	1.8	1	2.8	2.8	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	9.5%	11.2%	7.6%	4.2%
Adj EPS ⓘ	21%	82.1%	33.5%	20.5%
BVPSⓘ	14.1%	15.9%	19.5%	19.3%
Share Price	-	47.8%	-18.7%	-11.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	8	12.5	3.7	3	1.5	6.9	10.1	11.3	14.3	14.4	19
Op. Profit Mgn % ⓘ	5.5	7.7	5.7	2.8	3.2	4.3	6.1	6.8	8.9	9.6	8.3
Net Profit Mgn % ⓘ	1.7	3.6	1.3	0.8	0.5	1.8	2.9	3.2	4.7	5.5	6.4
Debt to Equity ⓘ	0.9	1.2	0.5	0.5	0.5	0.5	0.3	0.2	0.1	0.2	0
Working Cap Days ⓘ	170	240	252	205	250	172	173	160	176	208	100
Cash Conv. Cycle ⓘ	33	81	83	50	57	41	51	56	64	95	39

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	67	54	61	98	89	122	121	140	145	151
Operating Expenses ⓘ +	63	50	58	95	86	117	114	131	132	137
Manufacturing Costs	0	12	15	18	17	20	25	25	23	25
Material Costs	53	29	34	68	57	79	71	88	96	95
Employee Cost	4	4	4	3	4	5	5	6	6	6
Other Costs ⓘ	6	5	5	6	8	13	12	12	7	11
Operating Profit ⓘ	4	4	3	3	3	5	7	9	13	14
Operating Profit Margin (%)	5.5%	7.4%	5.7%	2.8%	3.2%	4.3%	6.1%	6.8%	8.9%	9.6%
Other Income ⓘ +	0	0	1	2	2	1	2	4	2	3
Exceptional Items ⓘ	0	-0	0	0	0	0	0	0	0	0
Interest ⓘ	1	1	2	1	1	1	1	1	1	1
Depreciation ⓘ	1	1	1	2	2	2	2	3	3	3
Profit Before Tax ⓘ	2	2	2	2	2	4	6	10	11	14
Tax ⓘ	1	0	1	1	1	1	2	3	3	3
Profit After Tax	1	2	1	2	2	3	5	7	8	10
PAT Margin (%)	1.7%	3.0%	2.0%	1.6%	1.8%	2.1%	4.0%	5.2%	5.7%	6.7%
Adjusted EPS (₹)	0.2	0.3	0.2	0.2	0.2	0.3	0.6	0.9	1.0	1.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Medico Remedies - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	15	16	27	28	30	32	37	44	52	62
Share Capital ⓘ	2	3	4	4	4	4	17	17	17	17
Reserves ⓘ	13	13	23	24	26	28	20	27	36	46
Debt +	14	19	12	13	12	13	10	8	7	14
Long Term Debt	4	11	2	2	5	5	1	0	0	0
Short Term Debt	10	8	10	10	7	8	9	8	7	14
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	15	12	18	33	26	25	27	31	32	35
Others Liabilities ⓘ	2	1	3	3	7	5	5	6	8	11
Total Liabilities ⓘ	46	48	59	76	75	76	79	89	98	122
Fixed Assets
Net Fixed Assets ⓘ +	7	7	7	12	13	15	18	22	21	21
Gross Block	14	15	15	22	24	29	32	39	41	44
Accumulated Depreciation	7	8	9	10	12	14	14	17	20	23
CWIP ⓘ	0	3	4	1	2	0	0	0	0	0
Investments ⓘ	1	0	0	0	0	1	0	1	2	2
Inventories	9	10	15	16	18	15	18	20	16	27
Trade Receivables	20	18	17	29	24	27	30	36	50	57
Cash Equivalents	1	1	1	1	1	3	2	1	0	1
Others Assets ⓘ	9	10	15	17	17	14	10	9	9	13
Total Assets ⓘ	46	48	59	76	75	76	79	89	98	122

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-4	-3	5	5	1	-11	6	8	2	5
PBT ⓘ	2	2	2	2	2	4	6	10	11	14
Adjustment ⓘ	2	2	2	2	2	3	3	3	4	2
Changes in Working Capital ⓘ	-7	-7	2	1	-3	-17	-1	-2	-9	-7
Tax Paid ⓘ	-1	-0	-1	-1	-1	-1	-2	-2	-3	-4
Cash Flow From Investing Activity ⓘ +	0	-3	-5	-4	-3	-17	-2	-7	-3	-3
Capex	-0	-4	-1	-3	-2	-17	-3	-7	-3	-3
Net Investments	1	-0	-1	0	-0	0	-0	-0	-0	-0
Others ⓘ	0	1	-4	-2	-1	0	1	0	0	-0
Cash Flow From Financing Activity ⓘ +	2	6	-1	-1	3	18	-6	-2	-0	-1
Net Proceeds from Shares ⓘ	0	0	9	0	0	4	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	5	0	0	0	0
Interest Paid ⓘ	-1	-1	-1	-1	-1	-1	-0	-0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	3	7	-8	0	3	10	-6	-2	-0	-1
Net Cash Flow ⓘ	-1	-0	-0	-0	0	-10	-2	-0	-1	1

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	7.97	10.47	5.67	5.72	5.61	8.31	13.94	18.01	17.23	17.58
ROCE (%)	10.86	9.39	9.05	7.79	7.66	10.13	15.09	21.88	21.9	21.65
Asset Turnover Ratio	1.64	1.22	1.15	1.44	1.17	1.62	1.57	1.67	1.55	1.37
PAT to CFO Conversion(x)	-4	-1.5	5	2.5	0.5	-3.67	1.2	1.14	0.25	0.5
Working Capital Days
Receivable Days	73.60	120.20	103.80	86.10	109.10	76.50	87.20	86.40	108	129.20
Inventory Days	47.50	61.60	74	57.90	70.70	48.90	49.30	49.10	45.40	52.10
Payable Days	98.20	169.40	160.20	134.70	187.40	119	135.30	120	119.20	127.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medico Remedies Ltd FAQs

The current trading price of Medico Remedies on 04-Jun-2026 16:59 is ₹45.83.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Medico Remedies stood at ₹380.3 Cr

The latest P/E ratio of Medico Remedies as of 03-Jun-2026 is 28.99.

The latest P/B ratio of Medico Remedies as of 03-Jun-2026 is 5.04.

The 52-week high of Medico Remedies is ₹57.00 and the 52-week low is ₹31.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medico Remedies is ₹206 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Medico Remedies Ltd is a average quality company.

The key valuation ratios of Medico Remedies Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Medico Remedies Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Medico Remedies Ltd

No data to display

Medico Remedies Ltd (MEDICO)

Medico Remedies Ltd (MEDICO)

Medico Remedies stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Medico Remedies - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medico Remedies Ltd FAQs

About Medico Remedies Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Medico Remedies Ltd (MEDICO)

Medico Remedies Ltd (MEDICO)

Medico Remedies stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Medico Remedies - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medico Remedies Ltd FAQs

What is the share price of Medico Remedies?

What is the market cap of Medico Remedies?

What is the P/E ratio of Medico Remedies?

What is the P/B ratio of Medico Remedies?

What is the 52-week high and low of Medico Remedies?

What is the TTM revenue of Medico Remedies?

Is Medico Remedies Ltd a good quality company?

Is Medico Remedies Ltd undervalued or overvalued?

Is Medico Remedies Ltd a good buy now?

About Medico Remedies Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.